Company profile
Avitar, Inc.
OTC: AVTI · Healthcare · Medical - Specialties
Canadian filerHQ Calgary, MAReports USD
#749 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 48
v0.1 · 5/100 weight · pillars only
↑ operating margin, listing tenure · ↓ market scale, balance-sheet leverage
Methodology →Revenue TTM
$2.7M
Rev growth YoY (TTM)
-47.4%
Net income (FY)
-$2.3M
Employees
36
as of 2026-07-12
Market cap
$1.4k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.1M$3.1M2007
Net income-$2.3M-$2.3M2007
Operating income$2.7M$2.7M2007
Total assets$1.7M$1.7M2007
Liabilities$11.6M$11.6M2007
Equity-$9.8M-$9.8M2007
Revenue trend
FY2000 – FY2007 · USD
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Avitar, Inc.’s revenue?
Avitar, Inc. booked $3.1M in FY2007 revenue, contracting 37% year over year — slower than 78% of Healthcare companies we track, at a -72.7% net margin.
Peers · Healthcare
American Medical Technologies Inc.——TransCanna Holdings Inc.——Aptevo Therapeutics Inc.35DAridis Pharmaceuticals, Inc.——Dyadic International, Inc.39DPolarean Imaging plc——Key facts
CEOCory H. Gelmon
SectorHealthcare
IndustryMedical - Specialties
HeadquartersCalgary, MA
ExchangeOTC: AVTI
Employees36
IPO date1994-10-31
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.